- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stryker Corporation (SYK)
Assess today's live Stryker Corporation (SYK) share price, performance and insights using our live NYSE: SYK stock exchange data.
Analyse the historical data and Stryker Corporation share price performance charts on this page. Our technical summary section provides analysis on Stryker share price buy/sell indicators using real-time data (or discuss the Stryker (SYK) stock price today with other investors in the Stryker NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE SYK share price (ISIN: US8636671013) to enhance your trading decisions with our free investment tools and resources.
What Is the Stryker Corporation Share Price Today?
The Stryker share price today is 358.29.
What Is the Stock Symbol for Stryker Corporation
The stock symbol (or 'ticker') for Stryker Corporation is "SYK."
What Stock Exchange Does Stryker Corporation Trade On?
Stryker Corporation is listed and trades on the NYSE stock exchange.
Is Stryker Corporation a Good Stock to Buy?
Determining whether Stryker Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Stryker Corporation share price performance charts on this page. Our technical summary section provides analysis on Stryker share price buy/sell indicators using real-time data (or discuss the Stryker (SYK) stock price today with other investors in the Stryker NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE SYK share price (ISIN: US8636671013) to enhance your trading decisions with our free investment tools and resources.
What Is the Stryker Corporation Share Price Today?
The Stryker share price today is 358.29.
What Is the Stock Symbol for Stryker Corporation
The stock symbol (or 'ticker') for Stryker Corporation is "SYK."
What Stock Exchange Does Stryker Corporation Trade On?
Stryker Corporation is listed and trades on the NYSE stock exchange.
Is Stryker Corporation a Good Stock to Buy?
Determining whether Stryker Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
354.48
364.81
52 wk Range
329.16
404.87
SYK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
354.48364.81
52 wk Range
329.16404.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.98%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.98%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SYK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
424.40
Upside
+18.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
13 analysts have revised their earnings downwards for the upcoming period
- Stryker receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Stryker group president Pierce sells $175k in shares
- Investing.com
- Form 144 Stryker Corp For: 2 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Stryker Company Profile
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Stryker Corporation SWOT Analysis
Financial Prowess | Stryker's robust financial health, consistent revenue growth, and strategic acquisitions position it as a formidable player in the medical technology secto |
Market Expansion | Delve into Stryker's entry into the $15 billion venous thromboembolism market through its Inari Medical acquisition, potentially driving substantial future growth |
Innovation Leade | Explore how Stryker's focus on robotics and advanced medical technologies, particularly its Mako system, is reshaping orthopedic surgery and market dynamics |
Analyst Outlook | With price targets ranging from $420 to $450, analysts remain bullish on Stryker's prospects, despite challenges like tariff impacts and integration risks |
Stryker Corporation Earnings Call Summary for Q4/2025
- Stryker reported Q4 2025 EPS of $4.47 (beating $4.39 forecast) and revenue of $7.2 billion (above $7.12B expected), with 11% organic sales growth and full-year sales exceeding $25 billion.
- Despite strong earnings, Stryker's stock dipped 0.99% in after-hours trading to $357.79, possibly reflecting broader market concerns or profit-taking.
- The Mako robotic system, now with over 3,000 installations worldwide, continues to drive growth, with U.S. market showing 11.2% organic growth versus 7.5% in international markets.
- For 2026, Stryker forecasts organic sales growth of 8-9.5% and adjusted EPS of $14.90-$15.10, though tariffs are expected to cost $400 million, potentially affecting margins.
- CEO Kevin Lobo expressed confidence in 'delivering growth at the high end of medtech' in 2026, highlighting the company's strong financial position for potential M&A opportunities.
Last Updated: 29/01/2026, 23:08
Read Full TranscriptCompare SYK to Peers and Sector
Metrics to compare | SYK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 42.2x | 26.1x | −0.5x | |
PEG Ratio | 5.12 | 0.63 | 0.00 | |
Price/Book | 6.1x | 2.6x | 2.6x | |
Price / LTM Sales | 5.5x | 2.9x | 3.3x | |
Upside (Analyst Target) | 19.3% | 16.4% | 45.6% | |
Fair Value Upside | Unlock | 17.1% | 5.8% | Unlock |
Analyst Ratings
21 Buy
8 Hold
1 Sell
Ratings:
30 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 424.40
(+18.45% Upside)
Earnings
Latest Release
Jan 29, 2026
EPS / Forecast
4.47 / 4.39
Revenue / Forecast
7.20B / 7.12B
People Also Watch
FAQ
What Is the Stryker (SYK) Share Price Today?
The live Stryker share price today is 358.29
What Stock Exchange Does Stryker (SYK) Trade On?
Stryker is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Stryker?
The stock symbol (also called a 'ticker') for Stryker is "SYK."
Does Stryker Pay Dividends? What’s The Current SYK Dividend Yield?
Yes, SYK Pays Dividends to its Shareholders. The current Stryker dividend yield is 0.98%.
What Is the Current Stryker Market Cap?
As of today, Stryker market capitalisation is 137.02B.
What Is Stryker's (SYK) Earnings Per Share (TTM)?
The Stryker EPS is currently 8.40 (Trailing Twelve Months).
When Is the Next Stryker Earnings Date?
Stryker's next earnings report will be released on 05 May 2026.
Is SYK a Buy or Sell From a Technical Analyst Perspective?
Based on today's Stryker moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Stryker Stock Split?
Stryker has split 9 times. (See the SYK stock split history page for full effective split date and price information.)
How Many Employees Does Stryker Have?
Stryker has 53000 employees.
What is the current trading status of Stryker (SYK)?
As of 09 Feb 2026, Stryker (SYK) is trading at a price of 358.29, with a previous close of 358.29. The stock has fluctuated within a day range of 354.48 to 364.81, while its 52-week range spans from 329.16 to 404.87.
What Is Stryker (SYK) Price Target According to Analysts?
The average 12-month price target for Stryker is USD424.40, with a high estimate of USD469 and a low estimate of USD316. 21 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +18.45% Upside potential.
What Is the SYK Premarket Price?
SYK's last pre-market stock price is 354.31. The pre-market share volume is 10.00, and the stock has decreased by -3.98, or -1.11%.
What Is the SYK After Hours Price?
SYK's last after hours stock price is 356.00, the stock has decreased by -2.29, or -0.64%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.